Vima LLC’s iShares Biotechnology ETF IBB Stock Holding History

Vima LLC’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-271	Closed	-$35K	–	189
2024 Q1	$35K	Buy	271 +141	+108%	+$19.3K	0.04%	137
2023 Q4	$16.4K	Buy	+130	New	+$15.9K	0.04%	205

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Vima LLC's IBB Position: Q2 2024 in Review

Vima LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 271 shares — an estimated $35K sold.

Vima LLC first reported a position in IBB in Q4 2023 and held it in 2 quarters. The position peaked at $35K in Q1 2024. 895 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Vima LLC reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Vima LLC sold 271 iShares Biotechnology ETF shares in Q2 2024, an estimated $35K.
Vima LLC first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 2 quarters.
Vima LLC's iShares Biotechnology ETF position peaked at $35K in Q1 2024.
895 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Vima LLC's 13F filing for Q2 2024, filed 8 Aug 2024.